Filing Details

Accession Number:
0000711377-17-000024
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-09-26 17:57:48
Reporting Period:
2017-09-25
Accepted Time:
2017-09-26 17:57:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1517426 J. Steven Quinlan 620 Lesher Place
Lansing MI 48912
Vp & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-09-25 2,772 $36.07 12,875 No 4 M Direct
Common Stock Disposition 2017-09-25 2,772 $73.54 10,103 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2017-09-25 2,772 $0.00 2,772 $36.07
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
81,950 2018-08-30 No 4 M Direct
Footnotes
  1. The options were granted on 8/30/2013, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant